{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:38:22Z","timestamp":1790757502130,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"10","funder":[{"name":"Merck Sharp & Dohme Spain","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Institut Universitari d\u2019Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria Jordi Gol","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,9,17]]},"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the prevalence and coprevalence of several chronic conditions in patients with type 2 diabetes in a Mediterranean region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two hundred and eighty-six primary care teams of the Catalonian Health Institute (Catalonia, Spain).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>We included patients aged \u226518 years with a diagnosis of type 2 diabetes by 31 December, 2016, who were registered in the Information System for the Development of Research in primary care (SIDIAP) database. We excluded patients with a diagnosis of type 1 diabetes, gestational diabetes mellitus and any other type of diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>\n                      We collected data on diabetes-related comorbidities (ie, chronic complications, associated cardiovascular risk factors and treatment complications). Diagnoses were based on the International Classification of Diseases, 10\n                      <jats:sup>th<\/jats:sup>\n                      Revision codes recorded in the database or, for some entities, on the cut-off points for a particular test result or a specific treatment indicated for that entity. The presence and stage of chronic kidney disease (CKD) were based on the glomerular filtration rate, the CKD Epidemiology Collaboration creatinine equation and the urine albumin-to-creatinine ratio.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 373\u2009185 patients were analysed. 82% of patients exhibited \u22652 comorbidities and 31% exhibited \u22654 comorbidities. The most frequent comorbidities were hypertension (72%), hyperlipidaemia (60%), obesity (45%), CKD (33%), chronic renal failure (CRF)(28%) and cardiovascular disease (23%). The most frequently coprevalent pairs of chronic conditions were the combination of hypertension with hyperlipidaemia (45%), obesity (35%), CKD (28%), CRF (25%) or cardiovascular disease (19%), as well as the combination of hyperlipidaemia with obesity (28%), CKD (21%), CRF (18%) or cardiovascular disease (15%); other common pairs of comorbidities were obesity\/CKD, obesity\/CRF, hypertension\/retinopathy, hypertension\/albuminuria, hypertension\/urinary tract infection, CVD\/CRF and CVD\/CKD, which were each present in more than 10% of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with type 2 diabetes have a high frequency of coprevalence of metabolic risk factors, cardiovascular disease and CKD and thus require an integrated management approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-031281","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T06:47:12Z","timestamp":1572331632000},"page":"e031281","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":66,"title":["Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study"],"prefix":"10.1136","volume":"9","author":[{"given":"Manel","family":"Mata-Cases","sequence":"first","affiliation":[{"name":"DAP-Cat Group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain"},{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[{"name":"DAP-Cat Group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain"},{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Real","sequence":"additional","affiliation":[{"name":"DAP-Cat Group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain"},{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cedenilla","sequence":"additional","affiliation":[{"name":"Medical Affairs, Merk Sharp & Dohme Spain, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[{"name":"CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain"},{"name":"Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"2025101812323689000_9.10.e031281.1","doi-asserted-by":"crossref","unstructured":"Buttorff C , Ruder T . Multiple chronic conditions in the United States. Santa Monica, CA: RAND Coorporation, 2017.","DOI":"10.7249\/TL221"},{"key":"2025101812323689000_9.10.e031281.2","unstructured":"Heide vander , Snoeijs S , Melchiorre MG , et al . Innovating care for people with multiple chronic conditions in Europe. NIVEL (Netherlands Institute for Health Services Research): Utrecht, 2015."},{"key":"2025101812323689000_9.10.e031281.3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2016.08.025","article-title":"Health care utilization of patients with multiple chronic diseases in the Netherlands: differences and underlying factors","volume":"35","author":"Hopman","year":"2016","journal-title":"Eur J Intern Med"},{"key":"2025101812323689000_9.10.e031281.4","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2016.1168291"},{"key":"2025101812323689000_9.10.e031281.5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1753-0407.12818","article-title":"Association between different types of comorbidity and disease burden in patients with diabetes","volume":"11","author":"An","year":"2019","journal-title":"J Diabetes"},{"key":"2025101812323689000_9.10.e031281.6","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s13300-018-0477-2","article-title":"Comorbidity type and health care costs in type 2 diabetes: a retrospective claims database analysis","volume":"9","author":"Lin","year":"2018","journal-title":"Diabetes Ther"},{"key":"2025101812323689000_9.10.e031281.7","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-1059","article-title":"The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque country","volume":"14","author":"Alonso-Mor\u00e1n","year":"2014","journal-title":"BMC Public Health"},{"key":"2025101812323689000_9.10.e031281.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1373-y","article-title":"The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort","volume":"17","author":"Nowakowska","year":"2019","journal-title":"BMC Med"},{"key":"2025101812323689000_9.10.e031281.9","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2018-211187"},{"key":"2025101812323689000_9.10.e031281.10","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.03.06.dc05-2078"},{"key":"2025101812323689000_9.10.e031281.11","first-page":"e23","article-title":"Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences","volume":"21","author":"Lin","year":"2015","journal-title":"Am J Manag Care"},{"key":"2025101812323689000_9.10.e031281.12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcjd.2015.09.002","article-title":"Comorbidity burden and health services use in community-living older adults with diabetes mellitus: a retrospective cohort study","volume":"40","author":"Gruneir","year":"2016","journal-title":"Can J Diabetes"},{"key":"2025101812323689000_9.10.e031281.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.04158.x"},{"key":"2025101812323689000_9.10.e031281.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000080","article-title":"The relationship of individual comorbid chronic conditions to diabetes care quality","volume":"3","author":"Magnan","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025101812323689000_9.10.e031281.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0313-2"},{"key":"2025101812323689000_9.10.e031281.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03282.x"},{"key":"2025101812323689000_9.10.e031281.17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diabres.2019.01.019","article-title":"Humanistic and economic burden of cardiovascular disease related comorbidities and hypoglycaemia among patients with type 2 diabetes in Japan","volume":"149","author":"Terauchi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"2025101812323689000_9.10.e031281.18","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.je.2016.12.012","article-title":"Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: Biobank Japan cohort","volume":"27","author":"Yokomichi","year":"2017","journal-title":"J Epidemiol"},{"key":"2025101812323689000_9.10.e031281.19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/17843286.2017.1348710","article-title":"Prevalence and co-prevalence of comorbidities in Belgian patients with type 2 diabetes mellitus: a transversal, descriptive study","volume":"73","author":"Hermans","year":"2018","journal-title":"Acta Clin Belg"},{"key":"2025101812323689000_9.10.e031281.20","doi-asserted-by":"publisher","DOI":"10.3109\/13814788.2012.714768"},{"key":"2025101812323689000_9.10.e031281.21","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmu056"},{"key":"2025101812323689000_9.10.e031281.22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.medcli.2012.01.020","article-title":"[SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research]","volume":"138","author":"Bol\u00edbar","year":"2012","journal-title":"Med Clin"},{"key":"2025101812323689000_9.10.e031281.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012463","article-title":"Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study","volume":"6","author":"Mata-Cases","year":"2016","journal-title":"BMJ Open"},{"key":"2025101812323689000_9.10.e031281.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025101812323689000_9.10.e031281.25","unstructured":"Organisation for Economic Co-operation and Development . Obesity update 2017. Paris, France: OECD, 2017."},{"key":"2025101812323689000_9.10.e031281.26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41440-017-0008-y","article-title":"Hypertension with diabetes mellitus complications","volume":"41","author":"Yamazaki","year":"2018","journal-title":"Hypertens Res"},{"key":"2025101812323689000_9.10.e031281.27","first-page":"589","article-title":"Associations between diabetic retinopathy and systemic risk factors","volume":"22","author":"Wat","year":"2016","journal-title":"Hong Kong Med J"},{"key":"2025101812323689000_9.10.e031281.28","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.11.1631"},{"key":"2025101812323689000_9.10.e031281.29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MOP.0000000000000586","article-title":"Obesity and chronic kidney disease","volume":"30","author":"Nehus","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"2025101812323689000_9.10.e031281.30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-6686.2012.00274.x","article-title":"Chronic kidney disease, diabetes mellitus and cardiovascular disease: risks and commonalities","volume":"38 Suppl 1","author":"Suckling","year":"2012","journal-title":"J Ren Care"},{"key":"2025101812323689000_9.10.e031281.31","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S008"},{"key":"2025101812323689000_9.10.e031281.32","unstructured":"Men\u00e9ndez SA . Actualizaci\u00f3n del algoritmo de hiperglucemia 2017. Diabetes pr\u00e1ctica 2017:57\u201360."},{"key":"2025101812323689000_9.10.e031281.33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002638","article-title":"Antihyperglycemic medication use among Medicare beneficiaries with heart failure, diabetes mellitus, and chronic kidney disease","volume":"9","author":"Patel","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025101812323689000_9.10.e031281.34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/dom.12658","article-title":"Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013","volume":"18","author":"Clemens","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"2025101812323689000_9.10.e031281.35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/03007995.2017.1416346","article-title":"Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease","volume":"34","author":"Huang","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"2025101812323689000_9.10.e031281.36","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0033"},{"key":"2025101812323689000_9.10.e031281.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(01)00255-8"},{"key":"2025101812323689000_9.10.e031281.38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00345-012-0934-x","article-title":"Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes","volume":"31","author":"Al-Rubeaan","year":"2013","journal-title":"World J Urol"},{"key":"2025101812323689000_9.10.e031281.39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.recesp.2011.07.017","article-title":"Validity for use in research on vascular diseases of the SIDIAP (information system for the development of research in primary care): the EMMA study","volume":"65","author":"Ramos","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"2025101812323689000_9.10.e031281.40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","article-title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-031281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:32:44Z","timestamp":1760815964000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-031281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,28]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/bmjopen-2019-031281"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-031281","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}